Literature DB >> 25345552

Concurrent deep-superficial dyspareunia: prevalence, associations, and outcomes in a multidisciplinary vulvodynia program.

Paul J Yong1, Leslie Sadownik, Lori A Brotto.   

Abstract

INTRODUCTION: Little is known about women with concurrent diagnoses of deep dyspareunia and superficial dyspareunia. AIM: The aim of this study was to determine the prevalence, associations, and outcome of women with concurrent deep-superficial dyspareunia.
METHODS: This is a prospective study of a multidisciplinary vulvodynia program (n = 150; mean age 28.7 ± 6.4 years). Women with superficial dyspareunia due to provoked vestibulodynia were divided into two groups: those also having deep dyspareunia (i.e., concurrent deep-superficial dyspareunia) and those with only superficial dyspareunia due to provoked vestibulodynia. Demographics, dyspareunia-related factors, other pain conditions, and psychological variables at pretreatment were tested for an association with concurrent deep-superficial dyspareunia. Outcome in both groups was assessed to 6 months posttreatment. MAIN OUTCOME MEASURES: Level of dyspareunia pain (0-10) and Female Sexual Distress Scale were the main outcome measures.
RESULTS: The prevalence of concurrent deep-superficial dyspareunia was 44% (66/150) among women with superficial dyspareunia due to provoked vestibulodynia. At pretreatment, on multiple logistic regression, concurrent deep-superficial dyspareunia was independently associated with a higher level of dyspareunia pain (odds ratio [OR] = 1.19 [1.01-1.39], P = 0.030), diagnosis of endometriosis (OR = 4.30 [1.16-15.90], P = 0.022), history of bladder problems (OR = 3.84 [1.37-10.76], P = 0.008), and more depression symptoms (OR = 1.07 [1.02-1.12], P = 0.007), with no difference in the Female Sexual Distress Scale. At 6 months posttreatment, women with concurrent deep-superficial dyspareunia improved in the level of dyspareunia pain and in the Female Sexual Distress Scale to the same degree as women with only superficial dyspareunia due to provoked vestibulodynia.
CONCLUSIONS: Concurrent deep-superficial dyspareunia is reported by almost half of women in a multidisciplinary vulvodynia program. In women with provoked vestibulodynia, concurrent deep-superficial dyspareunia may be related to endometriosis or interstitial cystitis, and is associated with depression and more severe dyspareunia symptoms. Standardized multidisciplinary care is effective for women with concurrent dyspareunia.
© 2014 International Society for Sexual Medicine.

Entities:  

Keywords:  Deep Dyspareunia; Provoked Vestibulodynia; Superficial Dyspareunia

Mesh:

Year:  2014        PMID: 25345552     DOI: 10.1111/jsm.12729

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Anatomic Sites and Associated Clinical Factors for Deep Dyspareunia.

Authors:  Paul J Yong; Christina Williams; Ali Yosef; Fontayne Wong; Mohamed A Bedaiwy; Sarka Lisonkova; Catherine Allaire
Journal:  Sex Med       Date:  2017-08-01       Impact factor: 2.491

2.  Deep Dyspareunia and Sexual Quality of Life in Women With Endometriosis.

Authors:  Leona K Shum; Mohamed A Bedaiwy; Catherine Allaire; Christina Williams; Heather Noga; Arianne Albert; Sarka Lisonkova; Paul J Yong
Journal:  Sex Med       Date:  2018-05-22       Impact factor: 2.491

3.  Endometriosis and Sexual Quality of Life.

Authors:  Mikal van Poll; Esther van Barneveld; Luca Aerts; Jacques W M Maas; Arianne C Lim; Bianca T A de Greef; Marlies Y Bongers; Nehalennia van Hanegem
Journal:  Sex Med       Date:  2020-07-22       Impact factor: 2.491

Review 4.  Endometriosis: A Review of Clinical Diagnosis, Treatment, and Pathogenesis.

Authors:  Saurabh Chauhan; Akash More; Vaishnavi Chauhan; Aditya Kathane
Journal:  Cureus       Date:  2022-09-06

5.  Deep Dyspareunia, Superficial Dyspareunia, and Infertility Concerns Among Women With Endometriosis: A Cross-Sectional Study.

Authors:  Kate J Wahl; Natasha L Orr; Michelle Lisonek; Heather Noga; Mohamed A Bedaiwy; Christina Williams; Catherine Allaire; Arianne Y Albert; Kelly B Smith; Susan Cox; Paul J Yong
Journal:  Sex Med       Date:  2020-02-13       Impact factor: 2.491

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.